P2P Partner Search Tool

Topic identifier & Title	SC1-HCO-14-2020: ERA-NET: Sustained collaboration of national and regional programmes in cancer research
Instrument	ERA-NET Cofund
Budget	5M€
Call closure	07 Apr 2020

List of organisations interested to join a consortium under this topic

Add me to the list

Organisation	Contact	Country	Description	P2P Networks involved
Early Drug Development Group	Maria Eugenia Riveiro (eugenia.riveiro@e2dg.com)	France	Early Drug Development Group (E2DG) is specialized in the early development of novel leads and targets in oncology. E2DG preclinical and clinical operations structure relies on an interdisciplinary team of medical oncologists, pharmacologists and molecular biology experts. In this sense, we are capable of offering professional services covering all stages of the early drug development program in oncology, from lead optimization to Phase I clinical trials. With more than 20 years of long track record in oncology drug development, we worked in the evaluation of over 20 different oncology leads (at least 8 first-in-man), covering both small molecules and monoclonal antibodies.	0

List of consortia which plan a submission under this topic and are still looking for additional parties

Add me as an organisation looking for partners